Xiamen Jiarong Technology Co., Ltd.
Issuance of Shares to Purchase Assets and Raise Supporting Funds and Related Party Transactions Report (Draft) (Revised)
| Project | Counterparty Name |
|---|---|
| Issuance of shares to purchase assets | Xiamen Puyu Investment Partnership (Limited Partnership), Lou Yongtong, Qing Bo, Chai Zhiguo, Deng Detao, Hangzhou Lanying Investment Management Partnership (Limited Partnership), Hangzhou Lanhe Enterprise Management Partnership (Limited Partnership), Chen Liang, Ye Guofei, Zhang Liying, Jiaxing Qiji Equity Investment Partnership (Limited Partnership), Jiaxing Qifei Equity Investment Partnership (Limited Partnership), Zhejiang Rushan High-tech Venture Investment Co., Ltd., Hangzhou Cobetter Filtration Equipment Co., Ltd., Ningbo Boshan Venture Investment Partnership (Limited Partnership), Zhuji Rushan Hui'an Venture Investment Partnership (Limited Partnership), Suzhou Chuanliu Chang'an New Material Venture Investment Partnership (Limited Partnership), Hangzhou Youchuang Sirui Venture Investment Partnership (Limited Partnership), CITIC Securities Investment Co., Ltd., and 19 other counterparties |
| Raising supporting funds | Xiamen Puyu Investment Partnership (Limited Partnership) |
Independent Financial Advisor
August 2026
Stock Code: 301148 Stock Abbreviation: Jiarong Technology Listing Venue: Shenzhen Stock Exchange
Statement of the Listed Company
The Company and all directors and senior management guarantee the truthfulness, accuracy, and completeness of the contents of this report and its summary, ensuring there are no false records, misleading statements, or major omissions, and assume individual and joint legal liability for the truthfulness, accuracy, and completeness of its contents. The Company's major shareholders, all directors, and senior management undertake that if the information disclosed or provided for this transaction is suspected of containing false records, misleading statements, or major omissions and is subject to investigation by judicial authorities or the China Securities Regulatory Commission (CSRC), they will not transfer the shares they hold in the listed company until the investigation conclusion is reached. They shall submit a written application for suspension of transfer and their stock account to the Company's Board of Directors within two trading days of receiving the notice of investigation, and the Board of Directors shall apply to the stock exchange and securities registration and clearing institution for locking the shares on their behalf. If the application for locking is not submitted within two trading days, they authorize the Board of Directors to verify and directly report their identity and account information to the stock exchange and securities registration and clearing institution to apply for locking. If the Board of Directors fails to report the information, they authorize the stock exchange and securities registration and clearing institution to directly lock the relevant shares. If the investigation concludes that there are violations, the undersigned commits that the locked shares will be voluntarily used for compensation arrangements for relevant investors.
The matters stated in this report and its summary do not represent a substantive judgment or guarantee by the CSRC or the Shenzhen Stock Exchange (SZSE) regarding the investment value of the Company's shares or investor returns, nor do they indicate that the CSRC or SZSE guarantees the truthfulness, accuracy, or completeness of this report and its summary. The effectiveness and completion of this transaction are subject to approval by the SZSE and registration by the CSRC. The matters stated herein do not represent a substantive judgment, confirmation, or approval by the CSRC, SZSE, or other regulatory authorities regarding the major asset restructuring.
Upon completion of this transaction, the Company is responsible for its own operational and earnings changes; investors are responsible for their own investment risks arising from this transaction. When evaluating this major asset restructuring, investors should carefully consider the risk factors disclosed in this report in addition to the content of this report and related documents disclosed simultaneously. Investors with any questions regarding this report should consult their stockbroker, lawyer, professional accountant, or other professional advisor.